Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

about

Challenges to advancing the evidence base for nephrology: the time is right for collaboration.

P2860

Q54580362-EC040D8D-3776-4165-B01A-CF237ED9C2BD

P2860

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

Item

http://www.wikidata.org/entity/Q38125509

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

@en

type

Item

label

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

@en

prefLabel

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

@en

P1476

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

@en

P2093

Bartosz Olechowski

http://www.w3.org/2001/XMLSchema#string

Donah Zachariah

http://www.w3.org/2001/XMLSchema#string

Paul R Kalra

http://www.w3.org/2001/XMLSchema#string

P2860

Galectin-3 regulates myofibroblast activation and hepatic fibrosis

Galectin-3 expression and secretion links macrophages to the promotion of renal fibrosis

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Natriuretic peptides: physiology, therapeutic potential, and risk stratification in ischemic heart disease.

Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure.

Cardio-renal syndromes: report from the consensus conference of the acute dialysis quality initiative

Serum neutrophil gelatinase-associated lipocalin (NGAL) in predicting worsening renal function in acute decompensated heart failure.

Acute kidney injury in non-severe pneumonia is associated with an increased immune response and lower survival.

Cardiac remodeling--concepts and clinical implications: a consensus paper from an international forum on cardiac remodeling. Behalf of an International Forum on Cardiac Remodeling.

P304

128-139

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1755-6686.2013.12025.X

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2013-07-31T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23902278

http://www.w3.org/2001/XMLSchema#string

P921

biomarker

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

about

P2860

P2860

Clinical utility of biomarkers in chronic kidney disease and chronic heart failure.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921